SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001437749-24-002977
Filing Date
2024-02-02
Accepted
2024-02-02 17:05:02
Documents
99

Document Format Files

Seq Description Document Type Size
1 FORM S-1 mbrx20240129_s1.htm   iXBRL S-1 2698304
2 EXHIBIT 5.1 ex_621556.htm EX-5.1 9344
3 EXHIBIT 23.1 ex_621573.htm EX-23.1 2598
4 EXHIBIT FILING FEES ex_621555.htm EX-FILING FEES 15058
10 logo.jpg GRAPHIC 10565
  Complete submission text file 0001437749-24-002977.txt   11271995

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20230930.xsd EX-101.SCH 90481
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbrx-20230930_cal.xml EX-101.CAL 78853
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20230930_def.xml EX-101.DEF 602565
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20230930_lab.xml EX-101.LAB 423312
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20230930_pre.xml EX-101.PRE 653231
101 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20240129_s1_htm.xml XML 1637679
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671997 | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-276851 | Film No.: 24592577
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)